Xanthine oxidoreductase in respiratory and cardiovascular disorders (Q37111434)

18 August 2017

1 reference

title

Xanthine oxidoreductase in respiratory and cardiovascular disorders (English)

1 reference

18 August 2017

1 reference

Adel Boueiz

1 reference

18 August 2017

Mahendra Damarla

series ordinal

1 reference

18 August 2017

Paul M Hassoun

series ordinal

1 reference

18 August 2017

publication date

14 March 2008

1 reference

American Journal of Physiology - Lung Cellular and Molecular Physiology

18 August 2017

published in

1 reference

18 August 2017

volume

294

1 reference

18 August 2017

1 reference

18 August 2017

page(s)

L830-40

1 reference

Role of IP-10/CXCL10 in the progression of pancreatitis-like injury in mice after murine retroviral infection

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Uric acid and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Tumor necrosis factor-alpha increases reactive oxygen species by inducing spermine oxidase in human lung epithelial cells: a potential mechanism for inflammation-induced carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Febuxostat compared with allopurinol in patients with hyperuricemia and gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Failure of allopurinol to improve left ventricular stroke work after cardiopulmonary bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Enhanced Expression and Activity of Xanthine Oxidoreductase in the Failing Heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structure-based mechanism of conversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Uric acid and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Oxidative stress and cardiovascular injury: Part II: animal and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Xanthine oxidase-dependent regulation of hypoxia-inducible factor in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Coronary artery superoxide production and nox isoform expression in human coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Structure and function of xanthine oxidoreductase: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Upregulation of xanthine oxidase by lipopolysaccharide, interleukin-1, and hypoxia. Role in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Endothelial barrier dysfunction caused by LPS correlates with phosphorylation of HSP27 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Transcriptional regulation of human xanthine dehydrogenase/xanthine oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Binding of xanthine oxidase to vascular endothelium. Kinetic characterization and oxidative impairment of nitric oxide-dependent signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Vascular failure: A new clinical entity for vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Adrenomedullin ameliorates lipopolysaccharide-induced acute lung injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Apical membrane targeting and trafficking of the human proton-coupled transporter in polarized epithelia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

A randomized controlled trial of allopurinol in coronary bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Endotoxin challenge increases xanthine oxidase activity in cattle: effect of growth hormone and vitamin E treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Endotoxin-induced acute lung injury and organ dysfunction are attenuated by pentobarbital anaesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Phosphorylation of xanthine dehydrogenase/oxidase in hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Cytoskeletal changes in hypoxic pulmonary endothelial cells are dependent on MAPK-activated protein kinase MK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Cytokine-mediated xanthine oxidase upregulation in chronic obstructive pulmonary disease's airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Characterization of the magnitude and kinetics of xanthine oxidase-catalyzed nitrate reduction: evaluation of its role in nitrite and nitric oxide generation in anoxic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Inhibition by terbutaline of nitric oxide and superoxide anion levels of endotoxin-induced organs injury in the anesthetized rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Posttranslational inactivation of human xanthine oxidoreductase by oxygen under standard cell culture conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Plasma and BAL Cytokine Response to Corticosteroid Rescue Treatment in Late ARDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Oxidative stress, antioxidants, and vascular damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Effects of inducible nitric oxide synthase and xanthine oxidase inhibitors on SEB-induced interstitial pneumonia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Effect of azapropazone and allopurinol on myocardial infarct size in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Hypercholesterolemia increases endothelial superoxide anion production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Xanthine oxidoreductase is an endogenous regulator of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Xanthine oxidoreductase in human mammary epithelial cells: activation in response to inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Vascular segmental permeabilities at high peak inflation pressure in isolated rat lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Identification of uric acid and xanthine oxidase in atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Hypoxia-induced acute lung injury in murine models of sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Plasma hypoxanthine levels in ARDS: implications for oxidative stress, morbidity, and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Oxygen-derived free radicals and postischemic myocardial reperfusion: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Incidence and outcomes of acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Randomised controlled trial of allopurinol prophylaxis in very preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Oxygen sensing by HIF hydroxylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Lack of cardioprotective efficacy of allopurinol in coronary artery surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Molecular basis of atrial fibrillation: a dream or a reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Xanthine oxidase activity in the dexamethasone-induced hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

The acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Oxidative pathways in cardiovascular disease: roles, mechanisms, and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Involvement of inducible nitric oxide synthase in the inflammatory process of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Mononuclear Phagocyte Xanthine Oxidoreductase Contributes to Cytokine-Induced Acute Lung Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Reactive oxygen species in vascular wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Generation of Nitric Oxide by a Nitrite Reductase Activity of Xanthine Oxidase: A Potential Pathway for Nitric Oxide Formation in the Absence of Nitric Oxide Synthase Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

Xanthine oxidase activity in bronchoalveolar lavage fluid from patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00007.2008

10.1152/AJPLUNG.00007.2008

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference